Global Amyloid Peptides Market Outlook
Report Highlights
What is Amyloid Peptide?
Amyloids peptide is a soluble peptide of 40 or 42 amino acids. It is filamentous protein deposits, made up of long, insoluble ordered fibres, are glycoproteins deposited extracellularly in tissues in amyloidosis. It is composed of aggregated peptide beta-sheets formed from parallel or anti-parallel alignments of peptide beta-strands. Its size ranges from nanometres to microns. Amyloids peptide are used mostly for research purpose. Of which, Alzheimer's disease, Diabetes mellitus type 2, Rheumatoid arthritis are major research areas.
Global Amyloid Peptides Market Outlook
Amyloid peptide-based drugs have emerged as a major class of therapeutics, and as a result of extensive efforts of researchers and pharmaceutical companies. During the last decade has witnessed impressing scientific interest in their therapeutic uses due to the increasing incidence of Alzheimer's. Amyloid peptides have gained popularity as one of the most investigated molecules in Alzheimer Decease research projects and efforts are being made globally to develop peptide-based compounds for the initial diagnosis and treatment of Alzheimer Decease.
From the past few decades, Alzheimer Decease and its related risk factors have become major healthcare concerns in many developed countries. In addition, it has been reported, Alzheimer Decease as the fifth-leading cause of death among the population aged above 65 years. According to Alzheimer’s Association, 2017, incidence exceeds five million cases per year in the United States and World Health Organization (WHO) predicted that the prevalence of Alzheimer's Decease worldwide will multiply to reach approximately 114 million by 2050. Recently, several research groups, found that Amyloid peptide vaccination chronically lower Alzheimer's Decease levels and reduces Alzheimer's Decease -associated pathology. Also, amyloid peptides have been implicated in cancer development, experimental evidence shows that amyloid peptides are capable of inhibiting tumour cell growth, while the evidence from clinical trials does not favour the role for amyloid peptides in the suppression of cancer, but it is possible to play an indirect role by intercepting oncogenic viruses.
Global Amyloid Peptides Market Competitive Landscape
The “Global Amyloid Peptides Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as AmideBio, Cambridge Research Biochemicals, BioLegend, AnaSpec, Inc, rPeptide, Genscript, Bio-Synthesis, NovoPro Inc. and Bachem. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.